Vilor-Tejedor, Natalia https://orcid.org/0000-0003-4935-6721
Operto, Grégory
Evans, Tavia E.
Falcon, Carles
Crous-Bou, Marta
Minguillón, Carolina
Cacciaglia, Raffaele
Milà-Alomà, Marta
Grau-Rivera, Oriol
Suárez-Calvet, Marc
Garrido-Martín, Diego
Morán, Sebastián
Esteller, Manel
Adams, Hieab H.
Molinuevo, José Luis
Guigó, Roderic
Gispert, Juan Domingo https://orcid.org/0000-0002-6155-0642
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Effect of BDNF Val66Met on hippocampal subfields volumes and compensatory interaction with APOE-ε4 in middle-age cognitively unimpaired individuals from the ALFA study
https://doi.org/10.1007/s00429-020-02125-3
Incidental findings on brain MRI of cognitively normal first-degree descendants of patients with Alzheimer's disease: a cross-sectional analysis from the ALFA (Alzheimer and Families) project
https://doi.org/10.1136/bmjopen-2016-013215
Funding for this research was provided by:
European Union’s Horizon 2020 Marie Sklodowska-Curie action (752310)
Health Department of the Catalan Government; Health Research and Innovation Strategic Plan (SLT002/16/00201)
la Caixa Foundation (LCF/PR/GN17/10300004)
Ministerio de Economía y Competitividad (IEDI-2016-00690)
Ministerio de Economía y Competitividad (RYC-2013-13054)
Article History
Received: 23 April 2019
Accepted: 30 July 2020
First Online: 17 August 2020
Compliance with ethical standards
:
: JLM has served/serves as a consultant or at advisory boards for the following for-profit companies, or has given lectures in symposia sponsored by the following for-profit companies: Roche Diagnostics, Genentech, Novartis, Lundbeck, Oryzon, Biogen, Lilly, Janssen, Green Valley, MSD, Eisai, Alector, BioCross, GE Healthcare, ProMIS Neurosciences, NovoNordisk, Zambón, Cytox and Nutricia. The rest of the authors have no conflict of interest to declare.